Showing results (561-570 of 604) with videos related to
Sort By:
Pageof 61
Journal of Translational Autoimmunity|January 1, 2024
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE studyChiara Tani, Chiara Cardelli, Roberto Depascale, et al.Annals of the Rheumatic Diseases|January 28, 2021
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registryAnja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, et al.RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.Journal of Medical Genetics|November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT studyDerralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.The Journal of Allergy and Clinical Immunology. in Practice|October 2, 2024
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National CohortConstance Lahuna, Federica Defendi, Laurence Bouillet, et al.RMD Open|December 20, 2018
Systemic lupus erythematosus: state of the art on clinical practice guidelinesFarah Tamirou, Laurent Arnaud, Rosaria Talarico, et al.Journal of the American Society of Nephrology : JASN|August 12, 2015
Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GNMohamad Zaidan, Benjamin Terrier, Agnieszka Pozdzik, et al.RMD Open|November 1, 2022
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques-Eric Gottenberg, Aurore Chaudier, Yves Allenbach, et al.The Lancet. Rheumatology|January 23, 2024
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, Gaëlle Guettrot-Imbert, Véronique Le Guern, et al.Annals of the Rheumatic Diseases|April 11, 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyMuriel Elhai, Marouane Boubaya, Oliver Distler, et al.Pageof 61